focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,126.00
Bid: 1,129.00
Ask: 1,137.00
Change: -8.00 (-0.71%)
Spread: 8.00 (0.709%)
Open: 1,120.00
High: 1,165.00
Low: 1,120.00
Prev. Close: 1,134.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Management Team Invest $3 Million in Burford Stock

4 Apr 2022 07:00

RNS Number : 0618H
Burford Capital Limited
04 April 2022
 

 

4 April 2022

 

 

BURFORD'S MANAGEMENT TEAM INVEST $3 MILLION IN BURFORD STOCK

 

Burford Capital Limited, the leading global finance and asset management firm focused on law, today announces that Chief Executive Officer Christopher Bogart, Chief Investment Officer Jonathan Molot, Chief Financial Officer Kenneth Brause and Co-Chief Operating Officers Aviva Will and David Perla have in aggregate invested $3 million in Burford's stock since March 31, 2022.

 

All five executives used their cash compensation to make the investments, which occurred through the Burford employee deferred compensation plan.

 

With this additional investment, Messrs Bogart and Molot's combined personal cash investment in Burford ordinary shares of nil par value ("Shares") since 2019 has now reached approximately $15 million, in addition to their prior substantial holdings acquired earlier in Burford's life. Together, Messrs Bogart and Molot control almost 9% of Burford's Shares.

 

The investments made on March 31 and April 1 total approximately 300,000 Shares: 140,400 Shares to Mr Bogart, 140,191 Shares to Mr Molot, 5,269 Shares to Mr Brause and 15,168 Shares to Ms Will. Messrs Brause and Perla have made further investments for execution today; Mr. Perla's investment is expected to amount to approximately 12,000 Shares and Mr Brause to approximately 5,000 additional shares; they will be the subject of a separate notice in due course.

 

Further details about the Burford deferred compensation plan can be found in Burford's recently released annual report. In essence, Burford employees are able to elect to defer cash compensation, without incurring current taxes, into the plan, which in turn permits the full amount of that deferred compensation to be allocated to Burford Shares (or for other investment options). It is intended that the plan, as announced on Friday, will then go into the market and buy the Shares. This is a tax-efficient way for employees to continue to accumulate exposure to Burford's Shares.

 

A Notification of Dealing Form for each of the transactions mentioned above is included at the end of this announcement.

 

 

For further information, please contact:

 

Burford Capital Limited

Robert Bailhache, Head of Investor Relations, EMEA and Asia - email

+44 (0)20 3530 2023

Jim Ballan, Head of Investor Relations, Americas - email

+1 (646) 793 9176

Numis Securities Limited - NOMAD and Joint Broker

+44 (0)20 7260 1000

Giles Rolls

Charlie Farquhar

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

Tony White

 

 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the New York Stock Exchange (NYSE: BUR) and the London Stock Exchange (LSE: BUR), and it works with companies and law firms around the world from its principal offices in New York, London, Chicago, Washington, DC, Singapore, Sydney and Hong Kong.

 

For more information, please visit www.burfordcapital.com.

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a) Name

Christopher P. Bogart

2

Reason for the notification

(a) Position/status

A PDMR occupying the position of Chief Executive Officer

(b) Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a) Name

Burford Capital Limited

(b) LEI

549300FUKUWFYJMT2277

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) Description of the financial instrument, type of instrument

Ordinary Shares

Identification code

GG00BMGYLN96

(b) Nature of the transaction

Allocation of fully vested notional Ordinary Shares equivalent to a deferred amount of cash compensation under Burford's deferred compensation plan

(c) Price(s)and volume(s)

Price(s)

Volume(s)

$ 9.19

140,400

(d) Aggregated information

· Aggregated volume

· Price

N/A

(e) Date of the transaction

31 March 2022

 

(f) Place of the transaction

Outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a) Name

Jonathan Molot

2

Reason for the notification

(a) Position/status

A PDMR occupying the position of Chief Investment Officer

(b) Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a) Name

Burford Capital Limited

(b) LEI

549300FUKUWFYJMT2277

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) Description of the financial instrument, type of instrument

Ordinary Shares

Identification code

GG00BMGYLN96

(b) Nature of the transaction

Allocation of fully vested notional Ordinary Shares equivalent to a deferred amount of cash compensation under Burford's deferred compensation plan

(c) Price(s)and volume(s)

Price(s)

Volume(s)

$ 9.23

140,191

(d) Aggregated information

· Aggregated volume

· Price

N/A

(e) Date of the transaction

1 April 2022

 

(f) Place of the transaction

Outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a) Name

Kenneth Brause

2

Reason for the notification

(a) Position/status

A PDMR occupying the position of Chief Financial Officer

(b) Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a) Name

Burford Capital Limited

(b) LEI

549300FUKUWFYJMT2277

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) Description of the financial instrument, type of instrument

Ordinary Shares

Identification code

GG00BMGYLN96

(b) Nature of the transaction

Allocation of fully vested notional Ordinary Shares equivalent to a deferred amount of cash compensation under Burford's deferred compensation plan

(c) Price(s)and volume(s)

Price(s)

Volume(s)

$ 9.23

5,269

(d) Aggregated information

· Aggregated volume

· Price

N/A

(e) Date of the transaction

1 April 2022

 

(f) Place of the transaction

Outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a) Name

Aviva Will

2

Reason for the notification

(a) Position/status

A PDMR occupying the position of Co-Chief Operating Officer

(b) Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a) Name

Burford Capital Limited

(b) LEI

549300FUKUWFYJMT2277

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) Description of the financial instrument, type of instrument

Ordinary Shares

Identification code

GG00BMGYLN96

(b) Nature of the transaction

Allocation of fully vested notional Ordinary Shares equivalent to a deferred amount of cash compensation under Burford's deferred compensation plan

(c) Price(s)and volume(s)

Price(s)

Volume(s)

$ 9.23

15,168

(d) Aggregated information

· Aggregated volume

· Price

N/A

(e) Date of the transaction

1 April 2022

 

(f) Place of the transaction

Outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a) Name

Christopher P. Bogart

2

Reason for the notification

(a) Position/status

A PDMR occupying the position of Chief Executive Officer

(b) Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a) Name

Burford Capital Limited

(b) LEI

549300FUKUWFYJMT2277

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) Description of the financial instrument, type of instrument

Notional Ordinary Shares

Identification code

GG00BMGYLN96

(b) Nature of the transaction

Allocation of unvested notional Ordinary Shares pursuant to the provisions of Burford's deferred compensation plan due to vest in 2024

(c) Price(s)and volume(s)

Price(s)

Volume(s)

$ Nil

46,332

(d) Aggregated information

· Aggregated volume

· Price

N/A

(e) Date of the transaction

31 March 2022

 

(f) Place of the transaction

Outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a) Name

Jonathan Molot

2

Reason for the notification

(a) Position/status

A PDMR occupying the position of Chief Investment Officer

(b) Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a) Name

Burford Capital Limited

(b) LEI

549300FUKUWFYJMT2277

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) Description of the financial instrument, type of instrument

Notional Ordinary Shares

Identification code

GG00BMGYLN96

(b) Nature of the transaction

Allocation of unvested notional Ordinary Shares pursuant to the provisions of Burford's deferred compensation plan due to vest in 2024

(c) Price(s)and volume(s)

Price(s)

Volume(s)

$ Nil

46,263

(d) Aggregated information

· Aggregated volume

· Price

N/A

(e) Date of the transaction

1 April 2022

 

(f) Place of the transaction

Outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a) Name

Kenneth Brause

2

Reason for the notification

(a) Position/status

A PDMR occupying the position of Chief Financial Officer

(b) Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a) Name

Burford Capital Limited

(b) LEI

549300FUKUWFYJMT2277

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) Description of the financial instrument, type of instrument

Notional Ordinary Shares

Identification code

GG00BMGYLN96

(b) Nature of the transaction

Allocation of unvested notional Ordinary Shares pursuant to the provisions of Burford's deferred compensation plan due to vest in 2024

(c) Price(s)and volume(s)

Price(s)

Volume(s)

$ Nil

1,739

(d) Aggregated information

· Aggregated volume

· Price

N/A

(e) Date of the transaction

1 April 2022

 

(f) Place of the transaction

Outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a) Name

Aviva Will

2

Reason for the notification

(a) Position/status

A PDMR occupying the position of Co-Chief Operating Officer

(b) Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a) Name

Burford Capital Limited

(b) LEI

549300FUKUWFYJMT2277

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) Description of the financial instrument, type of instrument

Notional Ordinary Shares

Identification code

GG00BMGYLN96

(b) Nature of the transaction

Allocation of unvested notional Ordinary Shares pursuant to the provisions of Burford's deferred compensation plan due to vest in 2024

(c) Price(s)and volume(s)

Price(s)

Volume(s)

$ Nil

5,006

(d) Aggregated information

· Aggregated volume

· Price

N/A

(e) Date of the transaction

1 April 2022

 

(f) Place of the transaction

Outside a trading venue

 

 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford.

 

This release does not constitute an offer of any Burford fund. Burford Capital Investment Management LLC, which acts as the fund manager of all Burford funds, is registered as an investment adviser with the US Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential private placement memorandum and other offering documents.

 

Forward-looking statements

This announcement contains "forward-looking statements" within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, regarding assumptions, expectations, projections, intentions and beliefs about future events. These statements are intended as "forward-looking statements". In some cases, predictive, future-tense or forward-looking words such as "aim", "anticipate", "believe", "continue", "could", "estimate", "expect", "forecast", "guidance", "intend", "may", "plan", "potential", "predict", "projected", "should" or "will" or the negative of such terms or other comparable terminology are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. In addition, we and our representatives may from time to time make other oral or written statements which are forward-looking statements, including in our periodic reports that we file with, or furnish to, the US Securities and Exchange Commission, other information sent to our security holders and other written materials. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and are based on numerous assumptions, expectations, projections, intentions and beliefs and that our actual results of operations, including our financial position and liquidity, and the development of the industry in which we operate, may differ materially from (and be more negative than) those made in, or suggested by, the forward-looking statements contained in this announcement. Significant factors that may cause actual results to differ from those we expect include those discussed under "Risk Factors" in our Annual Report on Form 20-F filed with the US Securities and Exchange Commission on March 29, 2022 and other reports or documents that we file with, or furnish to, the US Securities and Exchange Commission from time to time. In addition, even if our results of operations, including our financial position and liquidity, and the development of the industry in which we operate are consistent with the forward-looking statements contained in this announcement, those results of operations or developments may not be indicative of results or developments in subsequent periods.

 

Except as required by law, we undertake no obligation to update or revise the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAFLDEEKAEAA
Date   Source Headline
25th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
24th May 20223:30 pmRNSDirector/PDMR Shareholding
24th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
23rd May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
20th May 20225:38 pmRNSResult of AGM
20th May 20224:17 pmRNSPricing of Early Redemption of Bonds Due 2022
20th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
19th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
18th May 20228:00 amRNSNotice of Retail Shareholder Call on June 16, 2022
18th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
17th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
16th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
13th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
10th May 20228:00 amRNSNotice of Early Redemption of Bonds Due 2022
19th Apr 20227:00 amRNSAccess to Summary Judgment Filings in YPF Cases
13th Apr 20225:39 pmRNSCompleted Share Purchase by Employee Benefit Trust
13th Apr 202212:00 pmRNSNotice of 2022 AGM
12th Apr 20227:00 amRNSClosing of Private Offering of Senior Notes
11th Apr 20227:00 amRNSChristopher A. Halmy Nominated as Board Director
8th Apr 202211:30 amRNSDirector/PDMR Shareholding
7th Apr 20227:05 amRNSPricing and Upsizing of Senior Notes Offering
6th Apr 202211:30 amRNSDirector/PDMR Shareholding
4th Apr 20221:15 pmRNSPrivate Offering of Senior Notes
4th Apr 20227:00 amRNSManagement Team Invest $3 Million in Burford Stock
1st Apr 20225:59 pmRNSIntended Purchases of Ordinary Shares
29th Mar 202212:43 pmRNSAvailability of Annual Report
29th Mar 202212:13 pmRNSFull Year Results 2021
28th Mar 20227:00 amRNS$360m Pre-Settlement Investment Fund Close
15th Mar 202212:00 pmRNSNotice of FY21 Earnings Call Details
4th Mar 202212:00 pmRNSNotice of FY21 Results & Earnings Call
1st Mar 20224:53 pmRNSBurford Capital - $100m Equity Project Commitments
15th Feb 20227:00 amRNSUpdate on 2021 Business Activity & Accounting
8th Feb 20223:10 pmRNSBurford Capital's Affirmative Recovery Research
19th Jan 20224:30 pmRNSTR1 - Notification of Major Holdings
24th Dec 202110:00 amRNSTR1 - Notification of Major Holdings
23rd Dec 20217:00 amRNSStatement concerning non-cash accrual
15th Nov 20213:00 pmRNSSterling FX Rate for 2021 Interim Dividend
3rd Nov 20212:00 pmRNSDirector/PDMR Shareholding
2nd Nov 202111:57 amRNSMaterials for Investor Event
12th Oct 20212:00 pmRNSNotice of Investor Event Registration Details
27th Sep 202111:00 amRNSDirector/PDMR Shareholding
27th Sep 20218:30 amRNSCompleted Share Purchase by Employee Benefit Trust
20th Sep 20218:30 amRNSDirector/PDMR Shareholding
17th Sep 20218:30 amRNSDirector/PDMR Shareholding
16th Sep 20218:30 amRNSIntended Share Purchase by Employee Benefit Trust
16th Sep 20217:00 amRNSCompleted Share Purchase for NED Share Plan
15th Sep 202111:00 amRNSDirector/PDMR Shareholding
15th Sep 20218:30 amRNSIntended Share Purchase for NED Share Plan
9th Sep 202112:12 pmRNSNotice of Investor Event Date
9th Sep 202112:12 pmRNSInterim Results for six months ended 30 June 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.